Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Cardiopulmonary and metabolic responses during a 2-day CPET in myalgic encephalomyelitis/chronic fatigue syndrome: translating reduced oxygen consumption to impairment status to treatment considerations.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • معلومة اضافية
    • المصدر:
      Publisher: BioMed Central Country of Publication: England NLM ID: 101190741 Publication Model: Electronic Cited Medium: Internet ISSN: 1479-5876 (Electronic) Linking ISSN: 14795876 NLM ISO Abbreviation: J Transl Med Subsets: MEDLINE
    • بيانات النشر:
      Original Publication: [London] : BioMed Central, 2003-
    • الموضوع:
    • نبذة مختصرة :
      Background: Post-exertional malaise (PEM), the hallmark symptom of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), represents a constellation of abnormal responses to physical, cognitive, and/or emotional exertion including profound fatigue, cognitive dysfunction, and exertion intolerance, among numerous other maladies. Two sequential cardiopulmonary exercise tests (2-d CPET) provide objective evidence of abnormal responses to exertion in ME/CFS but validated only in studies with small sample sizes. Further, translation of results to impairment status and approaches to symptom reduction are lacking.
      Methods: Participants with ME/CFS (Canadian Criteria; n = 84) and sedentary controls (CTL; n = 71) completed two CPETs on a cycle ergometer separated by 24 h. Two-way repeated measures ANOVA compared CPET measures at rest, ventilatory/anaerobic threshold (VAT), and peak effort between phenotypes and CPETs. Intraclass correlations described stability of CPET measures across tests, and relevant objective CPET data indicated impairment status. A subset of case-control pairs (n = 55) matched for aerobic capacity, age, and sex, were also analyzed.
      Results: Unlike CTL, ME/CFS failed to reproduce CPET-1 measures during CPET-2 with significant declines at peak exertion in work, exercise time, V ˙ e, V ˙ O 2 , V ˙ CO 2 , V ˙ T , HR, O 2 pulse, DBP, and RPP. Likewise, CPET-2 declines were observed at VAT for V ˙ e/ V ˙ CO 2 , PetCO 2, O 2 pulse, work, V ˙ O 2 and SBP. Perception of effort (RPE) exceeded maximum effort criteria for ME/CFS and CTL on both CPETs. Results were similar in matched pairs. Intraclass correlations revealed greater stability in CPET variables across test days in CTL compared to ME/CFS owing to CPET-2 declines in ME/CFS. Lastly, CPET-2 data signaled more severe impairment status for ME/CFS compared to CPET-1.
      Conclusions: Presently, this is the largest 2-d CPET study of ME/CFS to substantiate impaired recovery in ME/CFS following an exertional stressor. Abnormal post-exertional CPET responses persisted compared to CTL matched for aerobic capacity, indicating that fitness level does not predispose to exertion intolerance in ME/CFS. Moreover, contributions to exertion intolerance in ME/CFS by disrupted cardiac, pulmonary, and metabolic factors implicates autonomic nervous system dysregulation of blood flow and oxygen delivery for energy metabolism. The observable declines in post-exertional energy metabolism translate notably to a worsening of impairment status. Treatment considerations to address tangible reductions in physiological function are proffered.
      Trial Registration Number: ClinicalTrials.gov, retrospectively registered, ID# NCT04026425, date of registration: 2019-07-17.
      (© 2024. The Author(s).)
    • References:
      J Appl Physiol Respir Environ Exerc Physiol. 1981 Aug;51(2):317-20. (PMID: 7263438)
      PLoS One. 2022 Mar 15;17(3):e0265315. (PMID: 35290404)
      Medicine (Baltimore). 2019 Oct;98(43):e17600. (PMID: 31651868)
      J Transl Med. 2020 Feb 24;18(1):100. (PMID: 32093722)
      Front Pediatr. 2018 Sep 04;6:242. (PMID: 30234078)
      Chest. 2022 Nov;162(5):1116-1126. (PMID: 35526605)
      Front Pediatr. 2018 Nov 15;6:352. (PMID: 30525014)
      Clin Neurophysiol Pract. 2020 Feb 08;5:50-58. (PMID: 32140630)
      Medicina (Kaunas). 2023 Dec 12;59(12):. (PMID: 38138257)
      J Clin Med. 2021 May 26;10(11):. (PMID: 34073494)
      Front Cell Neurosci. 2022 May 09;16:888232. (PMID: 35614970)
      Autoimmun Rev. 2023 Nov;22(11):103452. (PMID: 37742748)
      PLoS One. 2017 Apr 6;12(4):e0172894. (PMID: 28384329)
      Arthritis Rheum. 2006 Oct;54(10):3351-62. (PMID: 17009309)
      Pflugers Arch. 1973 Oct 17;343(2):151-6. (PMID: 4797851)
      Pulm Circ. 2015 Dec;5(4):610-8. (PMID: 26697168)
      Am Rev Respir Dis. 1984 Feb;129(2 Pt 2):S49-55. (PMID: 6421218)
      Front Physiol. 2020 Nov 04;11:585267. (PMID: 33250778)
      J Appl Physiol. 1955 Jul;8(1):73-80. (PMID: 13242493)
      IEEE J Sel Top Quantum Electron. 2016 May-Jun;22(3):. (PMID: 28070154)
      Arch Phys Med Rehabil. 2001 Oct;82(10):1421-4. (PMID: 11588748)
      Brain Behav Immun Health. 2023 Aug 07;32:100675. (PMID: 37600600)
      Chest. 2010 Oct;138(4):950-5. (PMID: 20522572)
      Medicina (Kaunas). 2023 Mar 15;59(3):. (PMID: 36984572)
      Spine J. 2009 Sep;9(9):754-9. (PMID: 19487163)
      Med Hypotheses. 2013 Sep;81(3):414-23. (PMID: 23790471)
      J Transl Med. 2020 Jan 6;18(1):4. (PMID: 31906988)
      J Appl Physiol (1985). 2002 Nov;93(5):1567-82. (PMID: 12381740)
      Med Sci Sports Exerc. 1996 Mar;28(3):359-65. (PMID: 8776224)
      Am Heart J. 1973 Apr;85(4):546-62. (PMID: 4632004)
      J Sports Sci. 2016;34(9):852-5. (PMID: 26238160)
      Annu Rev Nutr. 2017 Aug 21;37:371-393. (PMID: 28715993)
      J Transl Med. 2022 Mar 22;20(1):138. (PMID: 35317812)
      Medicina (Kaunas). 2021 Dec 29;58(1):. (PMID: 35056360)
      J Am Coll Cardiol. 1996 Feb;27(2):345-52. (PMID: 8557904)
      Work. 2020;66(2):247-256. (PMID: 32568145)
      Arch Intern Med. 2000 Nov 27;160(21):3270-7. (PMID: 11088089)
      J Sci Med Sport. 2001 Sep;4(3):357-66. (PMID: 11702922)
      Front Neurol. 2019 Jan 10;9:1033. (PMID: 30687207)
      J Transl Med. 2021 May 4;19(1):193. (PMID: 33947430)
      J Transl Med. 2020 Aug 15;18(1):314. (PMID: 32799889)
      Disabil Rehabil. 2012;34(13):1140-7. (PMID: 22181560)
      Phys Ther. 2013 Nov;93(11):1484-92. (PMID: 23813081)
      Front Pediatr. 2019 Mar 22;7:82. (PMID: 30968005)
      Neurosci Biobehav Rev. 2012 Feb;36(2):747-56. (PMID: 22178086)
      J Chiropr Med. 2016 Jun;15(2):155-63. (PMID: 27330520)
      PLoS One. 2016 Jul 18;11(7):e0159386. (PMID: 27428358)
      PLoS One. 2023 Feb 2;18(2):e0280942. (PMID: 36730360)
      Am J Transl Res. 2013;5(1):53-68. (PMID: 23390566)
      J Clin Med. 2020 Dec 14;9(12):. (PMID: 33327624)
      J Biophotonics. 2022 Apr;15(4):e202100246. (PMID: 34751510)
      Curr Rheumatol Rep. 2007 Dec;9(6):482-7. (PMID: 18177602)
      Sensors (Basel). 2021 May 28;21(11):. (PMID: 34071326)
      J Transl Med. 2021 Apr 21;19(1):162. (PMID: 33882940)
      PLoS One. 2018 Apr 2;13(4):e0195166. (PMID: 29608603)
      J Transl Med. 2019 Mar 14;17(1):80. (PMID: 30871578)
      ESC Heart Fail. 2020 Jun;7(3):1064-1071. (PMID: 32154656)
      Circulation. 2010 Jul 13;122(2):191-225. (PMID: 20585013)
      Auton Neurosci. 2021 Dec;236:102893. (PMID: 34649119)
      Healthcare (Basel). 2022 Oct 17;10(10):. (PMID: 36292504)
      Sports (Basel). 2023 May 29;11(6):. (PMID: 37368560)
      Chest. 2021 Aug;160(2):642-651. (PMID: 33577778)
      Chest. 2023 Sep;164(3):717-726. (PMID: 37054777)
      Thorax. 1993 Sep;48(9):894-8. (PMID: 8236071)
      Nat Commun. 2024 Feb 21;15(1):907. (PMID: 38383456)
      J Transl Med. 2022 Jun 17;20(1):273. (PMID: 35715857)
      Circ Heart Fail. 2009 Mar;2(2):113-20. (PMID: 19808326)
      Br J Sports Med. 2014 Sep;48(18):1340-6. (PMID: 23757486)
      Healthcare (Basel). 2021 Jun 05;9(6):. (PMID: 34198913)
      Am J Case Rep. 2016 Oct 10;17:720-729. (PMID: 27721367)
      Blood Rev. 2023 Jul;60:101075. (PMID: 36963989)
      Mol Psychiatry. 2016 Feb;21(2):261-9. (PMID: 25824300)
      Healthcare (Basel). 2021 Jun 05;9(6):. (PMID: 34198946)
      Front Physiol. 2022 Jul 06;13:924557. (PMID: 35874535)
      J Altern Complement Med. 2020 Jul;26(7):547-556. (PMID: 32579021)
      Front Physiol. 2013 May 16;4:115. (PMID: 23720638)
      Med Sci Sports Exerc. 1982;14(5):377-81. (PMID: 7154893)
      Can J Appl Physiol. 1996 Apr;21(2):79-89. (PMID: 8727472)
      Proc Natl Acad Sci U S A. 2017 Aug 22;114(34):E7150-E7158. (PMID: 28760971)
      Physiotherapy. 2022 Mar;114:85-95. (PMID: 34654554)
      Eur J Prev Cardiol. 2014 Apr;21(4):445-53. (PMID: 24398370)
      Auton Neurosci. 2013 Dec;179(1-2):131-7. (PMID: 24021938)
      J Clin Med. 2021 Jun 25;10(13):. (PMID: 34202023)
      Chest. 2020 Nov;158(5):2119-2129. (PMID: 32473950)
      Clin Ther. 2023 Dec;45(12):1228-1235. (PMID: 37802746)
      J Womens Health (Larchmt). 2010 Feb;19(2):239-44. (PMID: 20095909)
      Sci Adv. 2015 Feb;1(1):. (PMID: 26079000)
      Int J Sports Med. 1990 Feb;11(1):26-32. (PMID: 2318561)
      J Physiol. 1993 Oct;470:693-704. (PMID: 8308750)
      Nat Commun. 2023 May 31;14(1):3161. (PMID: 37258525)
      Clin Neurophysiol Pract. 2021 Sep 23;6:245-255. (PMID: 34667909)
      Complement Ther Med. 2019 Aug;45:179-184. (PMID: 31331557)
      JACC Heart Fail. 2021 Dec;9(12):927-937. (PMID: 34857177)
      Circulation. 2013 Mar 12;127(10):1157-64. (PMID: 23479667)
      Sports Med. 2021 Sep;51(9):1815-1834. (PMID: 33914281)
      PLoS One. 2014 Jan 14;9(1):e85276. (PMID: 24454832)
      Front Pediatr. 2019 Jan 08;6:412. (PMID: 30671425)
      Front Physiol. 2022 Feb 17;13:814965. (PMID: 35250618)
      J Transl Med. 2021 Nov 22;19(1):471. (PMID: 34809664)
      Neuropsychiatr Dis Treat. 2022 Nov 08;18:2599-2626. (PMID: 36387947)
      Nature. 2024 Jun;630(8017):695-703. (PMID: 38692285)
      Z Kardiol. 1994;83 Suppl 3:1-12. (PMID: 7941654)
      Neurosci Biobehav Rev. 2022 Jul;138:104711. (PMID: 35623448)
      J Am Coll Cardiol. 1996 Nov 15;28(6):1567-72. (PMID: 8917273)
      J Phys Ther Sci. 2016 Jan;28(2):635-40. (PMID: 27064327)
      Mayo Clin Proc. 2021 Nov;96(11):2861-2878. (PMID: 34454716)
      Int J Sports Phys Ther. 2013 Feb;8(1):62-73. (PMID: 23439921)
      PLoS One. 2022 Oct 20;17(10):e0276009. (PMID: 36264901)
      J Card Fail. 2008 May;14(4):283-9. (PMID: 18474340)
      Med Care. 1992 Jun;30(6):473-83. (PMID: 1593914)
      J Appl Physiol (1985). 2019 Mar 1;126(3):593-598. (PMID: 30543496)
      Support Care Cancer. 2019 Jul;27(7):2633-2641. (PMID: 30470892)
      Autoimmun Rev. 2020 Jun;19(6):102527. (PMID: 32247028)
      BMC Immunol. 2016 Mar 10;17:3. (PMID: 26965484)
      Front Neurol. 2021 Dec 17;12:769511. (PMID: 34975729)
      Cardiovasc Endocrinol Metab. 2022 Apr 12;11(2):e0261. (PMID: 35441129)
      J Sports Sci. 2020 Mar;38(5):590-596. (PMID: 31997716)
      Med Sci Sports Exerc. 2001 Sep;33(9):1463-70. (PMID: 11528333)
      J Appl Physiol (1985). 2001 May;90(5):1770-6. (PMID: 11299267)
      Circulation. 2011 Feb 15;123(6):668-80. (PMID: 21321183)
      Neurosci Biobehav Rev. 2022 Apr;135:104576. (PMID: 35167847)
      Med Hypotheses. 2018 Sep;118:142-145. (PMID: 30037603)
      Pulm Circ. 2016 Mar;6(1):55-62. (PMID: 27162614)
      Semin Arthritis Rheum. 2013 Oct;43(2):279-87. (PMID: 23838093)
      Psychol Med. 2020 Sep;50(12):1937-1948. (PMID: 32854795)
      Environ Anal Health Toxicol. 2022 Dec;37(4):e2022033-0. (PMID: 36916046)
      J Transl Med. 2014 Apr 23;12:104. (PMID: 24755065)
      Sci Rep. 2022 Oct 6;12(1):16762. (PMID: 36202885)
      Ann Intensive Care. 2019 Mar 13;9(1):37. (PMID: 30868286)
      Appl Physiol Nutr Metab. 2011 Jul;36 Suppl 1:S3-13. (PMID: 21800946)
      Chest. 2004 Sep;126(3):816-24. (PMID: 15364761)
      Disabil Rehabil. 2023 Nov;45(23):3788-3802. (PMID: 36345726)
      Front Neurosci. 2020 Apr 28;14:284. (PMID: 32410932)
      J Sport Health Sci. 2023 Jul;12(4):513-522. (PMID: 34314879)
      BMJ Open. 2022 May 2;12(5):e058128. (PMID: 35501074)
      Physiol Meas. 2022 May 25;43(5):. (PMID: 35483348)
      J Am Coll Cardiol. 2021 Sep 7;78(10):1056-1067. (PMID: 34474739)
      Front Physiol. 2021 Dec 14;12:771899. (PMID: 34970156)
      JCI Insight. 2022 May 9;7(9):. (PMID: 35358096)
      Eur J Appl Physiol Occup Physiol. 1986;54(6):656-60. (PMID: 3948861)
      IBRO Neurosci Rep. 2023 May 02;15:1-10. (PMID: 37303862)
      Br J Sports Med. 2008 Jul;42(7):620-1. (PMID: 17726065)
      Healthcare (Basel). 2020 Jun 30;8(3):. (PMID: 32629923)
      J Am Osteopath Assoc. 2007 Jun;107(6):218-24. (PMID: 17635902)
      Front Med (Lausanne). 2023 Jun 02;10:1187163. (PMID: 37342500)
      J Sports Sci. 2011 Jan;29(2):181-9. (PMID: 21170804)
      Int J Sports Med. 1991 Aug;12(4):369-73. (PMID: 1917220)
      Pflugers Arch. 2004 Mar;447(6):875-83. (PMID: 14740217)
      Proteomes. 2021 Jan 29;9(1):. (PMID: 33572894)
      J Lasers Med Sci. 2023 Oct 10;14:e41. (PMID: 38028882)
      J Clin Med. 2022 Nov 12;11(22):. (PMID: 36431185)
      Healthcare (Basel). 2020 Aug 14;8(3):. (PMID: 32823979)
      Cardiovasc Res. 2022 Jan 7;118(1):334-343. (PMID: 33538810)
      Medicines (Basel). 2020 Oct 15;7(10):. (PMID: 33076360)
      Clin Cardiol. 2008 Jul;31(7):328-33. (PMID: 18636530)
      Brain Sci. 2022 Aug 04;12(8):. (PMID: 36009101)
      Healthcare (Basel). 2021 Aug 03;9(8):. (PMID: 34442121)
      J Transl Med. 2010 Oct 11;8:93. (PMID: 20937116)
      Metabolites. 2020 May 25;10(5):. (PMID: 32466160)
      Am J Cardiol. 1985 Jan 11;55(2):22A-31A. (PMID: 3966407)
      J Neurol Sci. 2014 Jul 15;342(1-2):79-87. (PMID: 24825731)
      Am Heart J. 2000 Apr;139(4):649-53. (PMID: 10740147)
      Sports Health. 2022 Sep-Oct;14(5):687-693. (PMID: 34428975)
      J Appl Physiol. 1976 Oct;41(4):544-50. (PMID: 985399)
      Healthcare (Basel). 2020 Jun 13;8(2):. (PMID: 32545797)
      Cardiol Clin. 1992 Nov;10(4):705-17. (PMID: 1423382)
      Front Neuroendocrinol. 2022 Jul;66:100995. (PMID: 35421511)
      Physiol Rep. 2020 Sep;8(17):e14564. (PMID: 32889791)
    • Grant Information:
      U54 NS105541 United States NS NINDS NIH HHS; UL1 TR002384 United States TR NCATS NIH HHS; UL1 TR 002384 United States TR NCATS NIH HHS; U54NS105541 Foundation for the National Institutes of Health
    • Contributed Indexing:
      Keywords: Autonomic dysfunction; Cardiopulmonary exercise test; Chronic fatigue syndrome; Fatigue; Functional impairment; ME/CFS; Post exertional malaise; Two-day CPET
    • Molecular Sequence:
      ClinicalTrials.gov NCT04026425
    • الموضوع:
      Date Created: 20240704 Date Completed: 20240705 Latest Revision: 20240718
    • الموضوع:
      20240718
    • الرقم المعرف:
      PMC11229500
    • الرقم المعرف:
      10.1186/s12967-024-05410-5
    • الرقم المعرف:
      38965566